| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
NNC 55-0396 dihydrochloride manufacturers
- NNC 55-0396
-
- $60.00
-
2026-07-15
- CAS:357400-13-6
- Purity: 99.00%
- Supply Ability: 10g
- NNC 55-0396
-
- $60.00
-
2026-07-15
- CAS:357400-13-6
- Purity: 99.00%
- Supply Ability: 10g
|
| | NNC 55-0396 dihydrochloride Basic information |
| Product Name: | NNC 55-0396 dihydrochloride | | Synonyms: | (1S,2S)-2-[2-[[3-(1H-BENZIMIDAZOL-2-YL)PROPYL]METHYLAMINO]ETHYL]-6-FLUORO-1,2,3,4-TETRAHYDRO-1-(1-METHYLETHYL)-2-NAPHTHALENYL CYCLOPROPANECARBOXYLATE DIHYDROCHLORIDE;NNC 55-0396 DIHYDROCHLORIDE;(1S,2S)-2-(2-((3-(1H-benzo[d]imidazol-2-yl)propyl)(methyl)amino)ethyl)-6-fluoro-1-isopropyl-1,2,3,4-tetrahydronaphthalen-2-yl cyclopropanecarboxylate dihydrochloride;NNC 55-0396 (Racemic Mixture);NNC 55-0396,inhibit,Ca2+ channels,Inhibitor,NNC 550396,NNC 55 0396,Calcium Channel,Ca channels;NNC 55-0396 2HCl;NNC 55-0396, 10 mM in DMSO;(1S,2S)-2-(2-{[3-(1H-Benzimidazol-2-Yl)Propyl](Methyl)Amino}Ethyl)-6-Fluoro-1-Isopropyl-1,2,3,4-Tetrahydro-2-Naphthalenyl Cyclopropa necarboxylate Dihydrochloride | | CAS: | 357400-13-6 | | MF: | C30H39ClFN3O2 | | MW: | 528.11 | | EINECS: | | | Product Categories: | | | Mol File: | 357400-13-6.mol |  |
| | NNC 55-0396 dihydrochloride Chemical Properties |
| Melting point | 174 - 179°C | | storage temp. | Desiccate at RT | | solubility | DMSO (Slightly), Water (Slightly) | | form | Solid | | color | White to Off-White | | Water Solubility | Soluble to 25 mM in water | | Stability: | Hygroscopic |
| | NNC 55-0396 dihydrochloride Usage And Synthesis |
| Description | NNC 55-0396 is a selective inhibitor of T-type calcium channels that blocks Cav3.1 in stably expressing HEK293 cells (IC50 = 6.8 μM) with no discernible effect on high voltage-activated (L-type) channels in INS-1 cells up to a concentration of 100 μM. NNC 55-0396 suppresses tremor in two murine models, the GABAA α1-null (20 mg/kg) and harmaline-induced (12.5 mg/kg) tremor models, and was better tolerated than mibefradil . In arterial smooth muscle cells, NCC 55-0396 (IC50 = 80 nM) inhibits voltage-dependent K+ channels but does not affect their voltage sensitivity. NNC 55-0396 (1-5 μM) also suppresses angiogenesis in vitro by inhibiting hypoxia-inducible factor-1α activity, and it slows tumor growth of flank xenografts of U87MG cells in mice when administered at 20 mg/kg. | | Uses | NNC 55-0396 is a calcium channel protein inhibitor. | | Definition | ChEBI: NNC 55-0396 dihydrochloride is t-type calcium channel blocker It has a role as a calcium channel blocker. | | Biological Activity | Highly selective T-type calcium channel blocker. Displays IC 50 values of 6.8 and > 100 μ M for inhibition of Cav3.1 T-type channels and HVA currents respectively in INS-1 cells. | | in vitro | nnc 55-0396 showed no effect against high voltage calcium channels at 100 μm, but inhibited t-type channels in hek293 cells with a potency comparable to that of mibefradil (ic50 6.8 versus 10.1 μm) [1]. | | in vivo | nnc 55-0396 was better tolerated than mibefradil in the horizontalwire test. to assess for a potential interaction with harmaline in the inverted wire grid test, mice was given nnc 55-0396, followed by harmaline or vehicle. nnc 55-0396 ameliorated harmaline-induced test deficits. in the gabaa α1-null model, nnc 55-0396 at 12.5 mg/kg suppressed harmaline-induced tremor by half by 20–100 min, whereas mibefradil at the same dose did not significantly affect tremor. in contrast to mibefradil, nnc 55-0396 was well tolerated and suppresses tremor, and exerts less cytochrome p450 inhibition [1]. | | IC 50 | 6.8 μm for cav3.1 t-type channel | | storage | Desiccate at RT | | references | [1] quesada a,bui ph,homanics ge,hankinson o,handforth a. comparison of mibefradil and derivative nnc 55-0396 effects on behavior, cytochrome p450 activity, and tremor in mouse models of essential tremor. eur j pharmacol.2011 may 20;659(1):30-6. |
| | NNC 55-0396 dihydrochloride Preparation Products And Raw materials |
|